205 related articles for article (PubMed ID: 16571954)
1. Sugammadex: a revolutionary approach to neuromuscular antagonism.
Kopman AF
Anesthesiology; 2006 Apr; 104(4):631-3. PubMed ID: 16571954
[No Abstract] [Full Text] [Related]
2. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
[TBL] [Abstract][Full Text] [Related]
3. [Possible clinical potential in reverting muscular block with sugammadex in anaesthesia and surgery].
Øberg E; Claudius C
Ugeskr Laeger; 2013 Feb; 175(7):428-32. PubMed ID: 23402253
[TBL] [Abstract][Full Text] [Related]
4. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
5. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
6. Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects.
Wu X; Oerding H; Liu J; Vanacker B; Yao S; Dahl V; Xiong L; Claudius C; Yue Y; Huang Y; Abels E; Rietbergen H; Woo T
BMC Anesthesiol; 2014; 14():53. PubMed ID: 25187755
[TBL] [Abstract][Full Text] [Related]
7. Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy.
Aouad MT; Alfahel WS; Kaddoum RN; Siddik-Sayyid SM
BMC Anesthesiol; 2017 Apr; 17(1):57. PubMed ID: 28399799
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex: another milestone in clinical neuromuscular pharmacology.
Naguib M
Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
[TBL] [Abstract][Full Text] [Related]
9. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
[TBL] [Abstract][Full Text] [Related]
10. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.
Kim JE; Chun HR
Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578
[TBL] [Abstract][Full Text] [Related]
11. Sugammadex and neostigmine dose-finding study for reversal of residual neuromuscular block at a train-of-four ratio of 0.2 (SUNDRO20)†,
Kaufhold N; Schaller SJ; Stäuble CG; Baumüller E; Ulm K; Blobner M; Fink H
Br J Anaesth; 2016 Feb; 116(2):233-40. PubMed ID: 26787792
[TBL] [Abstract][Full Text] [Related]
12. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.
de Boer HD; van Esmond J; Booij LH; Driessen JJ
Paediatr Anaesth; 2009 Dec; 19(12):1226-8. PubMed ID: 19863737
[TBL] [Abstract][Full Text] [Related]
13. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
14. [Reversal of rocuronium induced neuromuscular block with sugammadex in a patient with myasthenia gravis].
Nakamori E; Nitahara K; Sugi Y; Katori K; Matsuzaki A; Higa K
Masui; 2013 Aug; 62(8):972-4. PubMed ID: 23984578
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
Gaszynski T; Szewczyk T; Gaszynski W
Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861
[TBL] [Abstract][Full Text] [Related]
16. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
[TBL] [Abstract][Full Text] [Related]
17. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex. Findings vs. speculation.
Carron M; Ori C
Acta Anaesthesiol Scand; 2015 Aug; 59(7):946-7. PubMed ID: 25962433
[No Abstract] [Full Text] [Related]
18. Effect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/remifentanil anaesthesia.
Dahaba AA; Bornemann H; Hopfgartner E; Ohran M; Kocher K; Liebmann M; Wilfinger G; Metzler H
Br J Anaesth; 2012 Apr; 108(4):602-6. PubMed ID: 22315331
[TBL] [Abstract][Full Text] [Related]
19. Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathing.
Eikermann M; Zaremba S; Malhotra A; Jordan AS; Rosow C; Chamberlin NL
Br J Anaesth; 2008 Sep; 101(3):344-9. PubMed ID: 18559352
[TBL] [Abstract][Full Text] [Related]
20. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Anesthesiology; 2006 Apr; 104(4):718-23. PubMed ID: 16571967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]